CARDLYTICS, INC. (CDLX)
Cardlytics Second Quarter 2026 Financial Results Driven By Strong Operational Performance
XENCOR INC (XNCR)
Xencor Reports Second Quarter 2026 Financial Results
VANDA PHARMACEUTICALS INC. (VNDA)
Vanda Pharmaceuticals Reports Second Quarter 2026 Financial Results
CAPITAL BANCORP INC (CBNK)
Mulvihill Canadian Bank Enhanced Yield ETF Declares Monthly Distribution
BLACK DIAMOND THERAPEUTICS, INC. (BDTX)
Black Diamond Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
SUNRUN INC. (RUN)
Sunrun Reports Second Quarter 2026 Financial Results
EXPEDIA GROUP, INC. (EXPE)
Expedia Group Reports Second Quarter 2026 Results
SYNDAX PHARMACEUTICALS INC (SNDX)
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
MERCADOLIBRE INC (MELI)
MercadoLibre, Inc. Reports Second Quarter 2026 Financial Results
BLEND LABS, INC. (BLND)
Blend to Present at the Canaccord Genuity 46th Annual Growth Conference